We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$14.1B
AUM Growth
-$90M
Cap. Flow
-$394M
Cap. Flow %
-2.79%
Top 10 Hldgs %
21.48%
Holding
1,980
New
111
Increased
767
Reduced
962
Closed
123

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.3M
2
AAPL icon
Apple
AAPL
+$12.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.1M
4
XOM icon
ExxonMobil
XOM
+$9.07M
5
ADP icon
Automatic Data Processing
ADP
+$7.98M

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Healthcare 8.93%
3 Consumer Discretionary 8.08%
4 Financials 7.53%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
1826
BioCryst Pharmaceuticals
BCRX
$2.31B
$98K ﹤0.01%
15,855
+34
+0.2% +$188
OABI icon
1827
OmniAb
OABI
$294M
$97.6K ﹤0.01%
26,028
-7,312
-22% -$33.3K
DBI icon
1828
Designer Brands
DBI
$339M
$95.8K ﹤0.01%
14,020
+1,377
+11% +$12.2K
VIAV icon
1829
Viavi Solutions
VIAV
$9.6B
$92.4K ﹤0.01%
13,444
-10,900
-45% -$84.8K
MRVI icon
1830
Maravai LifeSciences
MRVI
$946M
$90.5K ﹤0.01%
12,637
+1,364
+12% +$11.8K
BDN
1831
Brandywine Realty Trust
BDN
$551M
$89.4K ﹤0.01%
19,948
+1,647
+9% +$7.5K
PGP
1832
PIMCO Global StockPLUS & Income Fund
PGP
$101M
$87.4K ﹤0.01%
+11,572
New +$86.8K
FIGS icon
1833
FIGS
FIGS
$1.82B
$85.8K ﹤0.01%
16,107
+83
+0.5% +$424
ACDC icon
1834
ProFrac Holding
ACDC
$814M
$80.9K ﹤0.01%
10,916
-6,574
-38% -$54.5K
BSBR icon
1835
Santander
BSBR
$43.4B
$75.4K ﹤0.01%
15,266
-839
-5% -$4.49K
HBI
1836
DELISTED
Hanesbrands
HBI
$73.9K ﹤0.01%
14,982
-28,375
-65% -$139K
LCID icon
1837
Lucid Motors
LCID
$2.61B
$70.2K ﹤0.01%
2,691
-289
-10% -$7.71K
EOD
1838
Allspring Global Dividend Opportunity Fund
EOD
$283M
$69.8K ﹤0.01%
14,370
-45,209
-76% -$214K
QS icon
1839
QuantumScape Corp
QS
$3.4B
$63.7K ﹤0.01%
12,953
-1,825
-12% -$10.2K
AEF
1840
abrdn Emerging Markets Equity Income Fund
AEF
$368M
$61.1K ﹤0.01%
+11,574
New +$59.8K
LUMN icon
1841
Lumen
LUMN
$6.26B
$60.7K ﹤0.01%
55,165
+4,506
+9% +$5.71K
AMC icon
1842
AMC Entertainment Holdings
AMC
$2.38B
$58.6K ﹤0.01%
+11,759
New +$47.2K
MFG icon
1843
Mizuho Financial
MFG
$130B
$53.6K ﹤0.01%
+12,665
New +$50.2K
DNA icon
1844
Ginkgo Bioworks
DNA
$612M
$49.7K ﹤0.01%
3,762
-51,237
-93% -$1.53M
LESL icon
1845
Leslie's
LESL
$12.7M
$46.2K ﹤0.01%
+551
New +$53.6K
PTON icon
1846
Peloton Interactive
PTON
$2.82B
$43K ﹤0.01%
+12,712
New +$45.5K
NIU
1847
Niu Technologies
NIU
$192M
$42.7K ﹤0.01%
24,551
-3,329
-12% -$6.83K
AUR icon
1848
Aurora
AUR
$13.1B
$34.1K ﹤0.01%
+12,318
New +$34.1K
SABR icon
1849
Sabre
SABR
$838M
$33.4K ﹤0.01%
12,520
+252
+2% +$706
ABCL icon
1850
AbCellera Biologics
ABCL
$1.81B
$33.4K ﹤0.01%
11,284
-260
-2% -$984

Similar funds

Guggenheim Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Guggenheim Capital held 1,980 positions worth $14.1B, down 0.63% from $14.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Guggenheim Capital's Q2 2024 filing shows 111 new, 767 increased, 962 reduced and 123 closed positions. Its largest new stake was Arm: 48,961 shares worth $8.01M. The largest sale was VanEck Gold Miners ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2024 buy was Arm: 48,961 shares worth $8.01M.
  • Guggenheim Capital added most to Microsoft in Q2 2024, an estimated $17.3M increase.
  • Guggenheim Capital's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $19.6M.
  • Guggenheim Capital fully exited VanEck Gold Miners ETF in Q2 2024, selling an estimated $46.2M.
  • Guggenheim Capital's ten largest holdings make up 21% of its $14.1B portfolio in Q2 2024.
  • Guggenheim Capital opened 111 new positions and closed 123 in Q2 2024.
  • Guggenheim Capital's portfolio value fell 0.63% quarter-over-quarter to $14.1B.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.